亚洲AV成人片色在线观看高潮_亚洲精品成a人在线观看夫_日本久久久久久久久精品_亚洲精品无码成人在线观看

神經(jīng)鈣黏蛋白(NCAD)多克隆抗體

Polyclonal Antibody to N-cadherin (NCAD)

CDw325; CD325; CDHN; CDH2; Cadherin 2 Type 1; N-Cadherin

  • 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體 產(chǎn)品包裝(模擬)
  • 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體 產(chǎn)品包裝(模擬)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對NCAD的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別NCAD。

用法

Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。

贈品

相關產(chǎn)品

編號 適用物種:Mus musculus (Mouse,小鼠) 應用(僅供研究使用,不用于臨床診斷!)
RPB481Mu01 神經(jīng)鈣黏蛋白(NCAD)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Mu02 神經(jīng)鈣黏蛋白(NCAD)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPB481Mu03 神經(jīng)鈣黏蛋白(NCAD)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAB481Mu02 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體 WB; IHC; ICC; IP.
PAB481Mu01 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體 WB; IHC; ICC; IP.
PAB481Mu03 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體 WB; IHC; ICC; IP.
LAB481Mu71 神經(jīng)鈣黏蛋白(NCAD)多克隆抗體(生物素標記) WB; IHC; ICC.
SEB481Mu 神經(jīng)鈣黏蛋白(NCAD)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB481Mu 神經(jīng)鈣黏蛋白(NCAD)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻

雜志 參考文獻
Toxicology Letters Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients. [Pubmed: 23830989]
British journal of haematology Circulating N-cadherin levels are a negative prognostic indicator in patients with multiple myeloma. [Pubmed: 23438504]
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY Elevated Cerebrospinal Fluid and Plasma N-Cadherin in Alzheimer Disease [Pubmed: 32296844]
Cell Biol Toxicol ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer [33566221]
CELL BIOLOGY AND TOXICOLOGY Metastatic suppression by DOC2B is mediated by inhibition of epithelial-mesenchymal transition and induction of senescence [33758996]
Pharmacol Res DOC2B is a Negative Regulator of Wnt/β-catenin Signaling Pathway in Cervical Cancer [Pubmed:35500882]
留言咨詢